Gemcitabine and taxanes in metastatic breast cancer

被引：9

作者：

Amadori, D. ^{[1
]}

Cecconetto, L.

机构：

[1] Ist Sci Romagnolo Studio Cura Tumori, Mendola, Italy

[2] Morgagni Pierantoni Hosp, Dept Med Oncol, Forll, Italy

来源：

ANNALS OF ONCOLOGY | 2006年 / 17卷

关键词：

gemcitabine; metastatic breast cancer; taxanes; translational research;

D O I：

10.1093/annonc/mdj976

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：V173 / V176

页数：4

共 31 条

[1]

ALBAIN KS, 2004, P AM SOC CLIN ONCOL

[2]

Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer [J].

Alexopoulos, A ;

Tryfonopoulos, D ;

Karamouzis, MV ;

Gerasimidis, G ;

Karydas, I ;

Kandilis, K ;

Stavrakakis, J ;

Stavrinides, H ;

Georganta, C ;

Ardavanis, A ;

Rigatos, G .

ANNALS OF ONCOLOGY, 2004, 15 (01) :95-99

[3]

Gemcitabine as first-line therapy in patients with metastatic breast cancer: A phase II trial [J].

Blackstein, M ;

Vogel, CL ;

Ambinder, R ;

Cowan, J ;

Iglesias, J ;

Melemed, A .

ONCOLOGY, 2002, 62 (01) :2-8

[4]

Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: Results of a multicenter phase II study [J].

Brandi, M ;

Vici, P ;

Lopez, M ;

Valerio, MR ;

Giotta, F ;

Gebbia, N ;

Schittulli, F ;

Colucci, G .

SEMINARS IN ONCOLOGY, 2004, 31 (02) :13-19

[5]

Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer [J].

Brodowicz, T ;

Kostler, WJ ;

Möslinger, R ;

Tomek, S ;

Vaclavik, I ;

Herscovici, V ;

Wiltschke, C ;

Steger, GG ;

Wein, W ;

Seifert, M ;

Kubista, E ;

Zielinski, CC .

BREAST, 2000, 9 (06) :338-342

[6]

CAHN S, 2005, P AM SOC CLIN ONC P

[7]

ADVANCED BREAST-CANCER - A PHASE-II TRIAL WITH GEMCITABINE [J].

CARMICHAEL, J ;

POSSINGER, K ;

PHILLIP, P ;

BEYKIRCH, M ;

KERR, H ;

WALLING, J ;

HARRIS, AL .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) :2731-2736

[8]

COLOMER R, 2000, P AM SOC CLIN ONCOL, V19

[9]

Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study [J].

Conte, PF ;

Gennari, A ;

Donati, S ;

Salvadori, B ;

Baldini, E ;

Bengala, C ;

Pazzagli, I ;

Orlandini, C ;

Danesi, R ;

Fogli, S ;

Del Tacca, M .

BREAST CANCER RESEARCH AND TREATMENT, 2001, 68 (02) :171-179

[10]

DEFLINO C, 2002, P AM SOC CLIN ONCOL

← 1 2 3 4 →